Weakness
| Level | Key Signs |
|---|---|
| Upper motor neuron (UMN) — cortex, corticospinal tract | Spasticity, hyperreflexia, extensor plantar (Babinski), weakness of upper-limb extensors + lower-limb flexors |
| Lower motor neuron (LMN) — anterior horn cell, nerve root, peripheral nerve | Flaccidity, hyporeflexia/areflexia, fasciculations, atrophy |
| Neuromuscular junction (NMJ) | Fatigable weakness, prominent ocular/bulbar/proximal muscles, reflexes preserved until severe |
| Muscle (myopathy) | Proximal > distal weakness, no sensory loss, normal or reduced reflexes, no fasciculations |
| Pattern | Likely Diagnosis |
|---|---|
| Ocular weakness (ptosis, diplopia) | MG, mitochondrial myopathy, OPMD, botulism |
| Facial + bulbar | MG, GBS, brainstem lesion, motor neuron disease |
| Proximal arm + shoulder girdle | FSH dystrophy, LGMD, polymyositis, LEMS |
| Proximal leg + hip girdle | LGMD, polymyositis, Duchenne/Becker, spinal canal stenosis |
| Distal > proximal | CMT, myotonic dystrophy, IBM, peroneal neuropathy |
| Respiratory weakness | GBS, MG, ALS, Pompe disease |
| Fluctuating weakness | MG, periodic paralysis, LEMS, MS |
| Exacerbated by exercise | MG, LEMS, metabolic myopathies (McArdle), periodic paralysis |
| Test | Use |
|---|---|
| CK (creatine kinase) | Markedly elevated in Duchenne, polymyositis, rhabdomyolysis; normal/mild in FSH, IBM, OPMD |
| EMG/nerve conduction | Distinguishes myopathy vs. neuropathy vs. NMJ disorder |
| AChR antibodies | MG (80–85% sensitivity for generalized disease) |
| MuSK antibodies | MG seronegative for AChR (4–6%) |
| Anti-GM1 antibodies | MMNCB |
| Myositis panel (anti-Jo-1, etc.) | Inflammatory myopathies; predicts ILD and malignancy association |
| Genetic testing | Hereditary neuropathies, muscular dystrophies |
| Muscle/nerve biopsy | When diagnosis remains unclear after above workup |
| Repetitive nerve stimulation | NMJ disorders (decremental response in MG; incremental in LEMS) |